Tissue Culture Technician

About Maxion

Maxion has engineered a new class of biologics by harnessing knottins, one of nature’s most potent modulators of ion channels and G protein-coupled receptors (GPCR). Combining a knottin with an antibody’s advantageous drug properties, we are developing transformative treatments that reach new levels of specificity and durability for patients with ion channel and GPCR-driven diseases. Initially focused on immunological diseases, heart disorders and chronic pain, our pipeline of proprietary KnotBody® molecules will access targets that have long remained beyond the reach of biologics.

Situated at Unity Campus in Cambridge, UK, Maxion Therapeutics fosters a dynamic and forward-thinking work environment underpinned by our scientific founders, who are trailblazers in antibody engineering. Led by our CEO, Dr Arndt Schottelius, our experienced leadership team boasts a stellar track record. Dr Schottelius has held senior leadership positions, successfully advancing therapeutics from research to late-stage clinical development and building valuable portfolios of drug candidates and pharma partnerships. Maxion’s co-founders, Dr John McCafferty (CTO) and Dr Aneesh Karatt Vellatt (CSO), previously co-founded IONTAS, and together invented KnotBody® technology. Dr McCafferty is also renowned for co-inventing antibody phage display, which contributed to the 2018 Nobel Prize in Chemistry (awarded to his co-inventor Sir Gregory Winter), and co-founding Cambridge Antibody Technology.

For more information please visit: https://www.maxiontherapeutics.com/.

About the Role

We are seeking a talented and highly motivated Tissue Culture Technician to join our team. Working within the Protein Sciences team, the successful candidate will have experience with cell culture techniques and help run our cell culture lab, working together with our Tissue Culture Facility Manager, helping the company achieve its challenging goals. Candidates should be comfortable with our agile, start-up culture and fast-paced, dynamic working environment.

 
Key responsibilities

• Routine maintenance of cell lines (adherent and suspension)
• Carry out routine transfections for protein expression on weekly basis
• Establish ion channel and GPCR cell lines to help facilitate our KnotBody discovery pipeline
• Collaborate with multiple discovery teams to facilitate bespoke cell culture requests
• Analyse, interpret and effectively communicate data verbally and in written form to team members
• Solve problems on a day-to-day basis

Desirable but not essential

• Experience with flow cytometry
  

Candidate Profile

The candidate will ideally possess a BSc in Life Sciences (e.g Cell Biology, Immunology) with substantial experience in working with cell culture.  Essential skills include:

• Excellent cell culture techniques
• Strong documentation and organisational skills
• Attention to detail and commitment to quality
• Excellent interpersonal skills with the ability to build collaborative working relationships
• Ability to meet deadlines

What can we offer you?

• A competitive salary based on experience
• A comprehensive benefits package including generous pension contribution, Private Life and Medical Insurance and a Cycle to Work Scheme.
• Located in a state-of-the art Science Park with easy access to Cambridge by car, train and bus, and offering on-site gym, cafe, and a vibrant social community.
• Significant opportunities for career progression within a dynamic company.
• Working alongside an innovative team of scientists, including the founders, who are Key Opinion Leaders in the field.
• A supportive work environment with a key focus on fostering collaborative working environment within a friendly team.

To apply for this position, click on the link to upload your CV and answer the required questions. The closing date for applications is Sunday 23rd August 2026.

This is a permanent position.

Agencies: We are recruiting this role directly with our in-house talent team, so do not need support from agencies.  We also have our own preferred suppliers list which is not being reviewed for additions in the next 12 months.